Treatment of advanced/metastatic urothelial cancer has changed dramatically in recent years. This review discusses the use, risks, and benefits of several novel therapies for this indication.
Andrew T. Ruplin, PharmD
Advertisement
Articles by Andrew T. Ruplin, PharmD
Advertisement
Latest Updated Articles
Evolving Standards of Care in the Systemic Treatment of Metastatic Urothelial CancerPublished: July 14th 2024 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Axatilimab: A New Frontier for Steroid-Refractory Chronic GVHD
2
CHEST 2025: Exploring the Link Between GLP-1 Receptor Agonists, Type 2 Diabetes, and Asthma Risk
3
Immunization and Vigilance: Preventing Infections in T-Cell Modifying Therapies
4
World Standards Week 2025: Advancing Quality and Patient Safety Standards to Shape Pharmacy Practice and Innovation
5
